>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Minggu, 12 September 2010

Credis Suisse INDOSAT (ISAT): 2010 Guidance higher revenue/margins, lower capex- Buy

I reiterate this is TIME to BUY ISAT given 1) Since New CEO in August 2009, 4Q-1Q-3Q Cellular continued to grow from 16.9% 3Q09 to 18.0%-18.2%-18.7%, 2) 2Q outperformance in term of growing QoQ Cellular Growth to back to #2 Operator with EBITDA margins growth, 3) NEW FY10 Management guidance, there is room for earnings upgrade, and 4) share price underperformance YTD and in the past 5 years! At Rp4,450- ISAT is trading on 15.9x-12.5x 2010F-11F, 4.8% 2011F Dividend Yield, and implying 60% upside to DCF Rp7,100 (implies 20x 2011F PER), we reiterate BUY ISAT!

· Colin McCallum (Daily attached): Indosat has finally released official guidance for FY10. Lack of guidance has arguably placed Indosat at a disadvantage in terms of investor “mind-share” in Indonesia, and has been misconstrued as a lack of control over the business by new management. Indosat’s FY10 guidance, just released, is for 16-17% cellular revenue growth, a 12-14% drop in non-wireless revenues, 48-49% EBITDA margins and capex of Rp8.5-9.0 tn. The only previous guidance released by management, on 11 May 2010, was for cash capex of Rp9.1-10.9 tn.

· We would reiterate that Indosat’s cellular revenue grew 7.7% QoQ into 2Q10, faster than Excelcom, which grew service revenue by 4.2% QoQ and Telkomsel (not listed) which grew revenue 5.7% QoQ into 2Q10. It seems hard to deny that implied 17.0% and 10.0% YoY cellular and total revenue growth figures, implied YoY EBITDA growth of circa 12.9%, and capex 20.4% lower YoY, all represent improving trends. Our OUTPERFORM rating is maintained.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News